Human Fibroblast Interferon for Clinical Trials: Pharmacokinetics and Tolerability in Experimental Animals and Humans

Human fibroblast interferon (F-interferon) purified by adsorption on controlled-pore glass was given intramuscularly to patients at daily dosages of up to 20 × 10(6) units. Serum levels of antiviral activity were low or undetectable. In contrast, reasonably high serum titers were found in patients r...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Billiau, Alfons, De Somer, Piet, Edy, Victor G., De Clercq, Erik, Heremans, Hubertine
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1979
Sujets:	Pharmacology and Therapeutics
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352788/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/475375/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.16.1.56
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!